Maurizio Rocco Averna
Overview
Explore the profile of Maurizio Rocco Averna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giammanco A, Noto D, Barbagallo C, Nardi E, Caldarella R, Ciaccio M, et al.
Life (Basel)
. 2021 Jul;
11(6).
PMID: 34207236
Hyperalphalipoproteinemia (HALP) is a lipid disorder characterized by elevated plasma high-density lipoprotein cholesterol (HDL-C) levels above the 90th percentile of the distribution of HDL-C values in the general population. Secondary...
2.
Barbagallo C, Cefalu A, Giammanco A, Noto D, Caldarella R, Ciaccio M, et al.
Life (Basel)
. 2021 Apr;
11(4).
PMID: 33916487
Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is...
3.
Noto D, Cottone S, Cefalu A, Vadala A, Barbagallo C, Rizzo M, et al.
Thromb Haemost
. 2007 Dec;
98(6):1362-7.
PMID: 18064337
In recent years new biomarkers able to measure the coronary atherosclerotic burden have been investigated. The aim of the present study was: i) to measure plasma levels of four biomarkers:...
4.
Noto D, Rizzo M, Barbagallo C, Cefalu A, Verde A, Fayer F, et al.
Metabolism
. 2006 Sep;
55(10):1308-16.
PMID: 16979400
Triglyceride-rich lipoproteins generated during the postprandial phase are atherogenic. Large very low-density lipoproteins (LDLs) or chylomicrons (CMs) are not as atherogenic as their remnants (Rem). Small and dense LDLs are...
5.
Noto D, Cefalu A, Barbagallo C, Pace A, Rizzo M, Marino G, et al.
Int J Cardiol
. 2005 May;
101(2):213-7.
PMID: 15882666
Background: Cystatin C is the most abundant protease inhibitor in the plasma. Low plasma levels have been found in patients with aortic aneurysms and they seem correlated with the extension...
6.
Carroccio A, Brusca I, Iacono G, Di Prima L, Teresi S, Pirrone G, et al.
Clin Chem
. 2005 Apr;
51(5):917-20.
PMID: 15855673
No abstract available.